Concentrix

Q3 FY2026 EarningsCNXC Q3 FY26 results were marked by a significant GAAP miss due to a $1.05B non-cash goodwill impairment charge, leading to a GAAP EPS of -$16.24 vs. $0.80 expected. Revenue of $2.45B was slightly below the $2.48B consensus, down 1.2% YoY, primarily due to weakness in Healthcare (-16.6% YoY) and Technology (-10.0% YoY). However, adjusted performance remained resilient, with Non-GAAP Diluted EPS of $2.92 beating the $2.70 consensus, driven by aggressive cost reduction initiatives and better-than-expected non-GAAP operating margins (12.6% vs. ~12.3% expected).